Publications by authors named "Martin Bonacci"

Claim this Profile
O
Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis.
Zobair M Younossi, Maria Stepanova, Fatema Nader, Rohit Loomba, Quentin M Anstee, Martin Bonacci

Clin Gastroenterol Hepatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.
Jerome Boursier, Hannes Hagström, Mattias Ekstedt, Clemence Moreau, Martin Bonacci

J Hepatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study.
Mary E Rinella, Jean-Francois Dufour, Quentin M Anstee, Zachary Goodman, Zobair Younossi, Martin Bonacci

J Hepatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.
Qian Chen, Celia Perales, María Eugenia Soria, Damir García-Cehic, Josep Gregori, Martin Bonacci

Antiviral Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HBeAg-Negative "Gray Zone" Phase: A Frequent Condition With Different Outcomes in Western and Asian Patients?
Martin Bonacci, Xavier Forns, Sabela Lens

Clin Gastroenterol Hepatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplified follow-up of patients with mild chronic hepatitis C in areas with limited access to antiviral therapy.
Sabela Lens, Ferran Torres, Martin Bonacci, Concepció Bartres, Anna Pocurull

Dig Liver Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort.
Marta Hernández-Conde, Inmaculada Fernández, Christie Perelló, Adolfo Gallego, Martin Bonacci

J Viral Hepat· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation.
Sabela Lens, María García-Eliz, Inmaculada Fernández, Lluis Castells, Martin Bonacci

Liver Int· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: STAT-4 polymorphism - a tool to personalise clinical practice in chronic HBV infection.
Martin Bonacci, Sabela Lens

Aliment Pharmacol Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
Martín Bonacci, Sabela Lens, Zoe Mariño, María-Carlota Londoño, Sergio Rodriguez-Tajes

Gastroenterology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C.
Javier Ampuero, Carlota Jimeno, Rosa Quiles, José Miguel Rosales, Susana Llerena, Martín Bonacci

J Hepatol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.
Martina Gambato, Noelia Caro-Pérez, Patricia González, Nuria Cañete, Zoe Mariño, Martín Bonacci

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals.
Martín Bonacci, Sabela Lens, María-Carlota Londoño, Zoe Mariño, Maria C Cid

Clin Gastroenterol Hepatol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in Special Populations: HIV/HCV Coinfection, Liver Transplantation and Patients with End-Stage Renal Disease.
Martín Bonacci, Sabela Lens, Zoe Mariño, Xavier Forns

Dig Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.
Martina Gambato, Noelia Caro-Pérez, Patricia González, Nuria Cañete, Zoe Mariño, Martín Bonacci

PLoS One· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV-decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list.
Martin Bonacci, Maria-Carlota Londoño, Nuria Esforzado, Xavier Forns, Jose-Miguel Sotoca

Transpl Int· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cost-efficacy of new antiviral treatments for chronic hepatitis C].
Sabela Lens, Martín Bonacci

Aten Primaria· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis